(August 17, 2023, 8:13 AM EDT) -- WASHINGTON, D.C. — A majority of the Federal Circuit U.S. Court of Appeals on Aug. 16 confirmed findings by the Patent Trial and Appeal Board that a patented prostate cancer treatment involving the placement of filler between tissue being targeted by radiation therapy and other, nearby tissue was anticipated by prior art....